Skip to main content
. 2022 Aug 25;107(12):2977–2982. doi: 10.3324/haematol.2022.281128

Table 2.

All-cause adverse events by Medical Dictionary for Drug Regulatory Activities preferred terms and highest Common Terminology Criteria for Adverse Events grade in patients with acute myleoid leukemia treated with BI 836858 in combination with decitabine: on treatment period.

graphic file with name 1072977.tab2.jpg